Table 3.
Annual medical expense of the cancer and comparison groups.a
|
|
Study group | |||||||||
| Category | Childhood cancer survivors (n=33,105) | Cancer groups (ICD-9-CMb) | Comparison group | |||||||
|
|
|
Hematologic cancer (200-208) (n=3934) | Brain cancer (191-192) (n=2241) | Benign brain tumor (225) (n=7825) | Non-CNSc solid tumor (140-190; 193-199) (n=19,105) | P valued | No cancer individuals (n=64,754) | P valuee | ||
| Total expense | 285.56 (161.78-535.80) | 268.48 (159.50-475.08) | 614.08 (267.05-1793.94) | 336.89 (184.64-652.14) | 257.78 (148.44-456.88) | <.001 | 203.90 (118.98-347.55) | <.001 | ||
| Outpatient | 239.81 (140.24-416.02) | 230.96 (138.51-368.64) | 473.60 (223.04-1380.48) | 274.76 (159.54-503.51) | 219.49 (129.69-362.93) | <.001 | 174.50 (103.38-280.90) | <.001 | ||
|
|
Hospital outpatient | 50.94 (10.46-165.40) | 45.48 (10.93-132.53) | 227.17 (42.62-1076.80) | 75.48 (18.91-236.87) | 39.37 (6.98-124.60) | <.001 | 20.56 (3.19-67.82) | <.001 | |
|
|
Community clinic | 150.78 (89.09-237.73) | 148.16 (92.35-232.70) | 172.90 (93.45-284.81) | 156.97 (91.28-248.53) | 146.74 (87.16-230.49) | <.001 | 131.03 (76.53-206.54) | <.001 | |
| Inpatient | 0.00 (0.00-36.49) | 0.00 (0.00-30.92) | 0.00 (0.00-142.36) | 0.00 (0.00-72.10) | 0.00 (0.00-0.00) | <.001 | 0.00 (0.00-0.00) | <.001 | ||
| Emergency | 8.45 (0.00-26.50) | 7.87 (0.00-23.44) | 14.29 (0.00-44.84) | 10.54 (0.00-32.22) | 7.25 (0.00-23.59) | <.001 | 5.31 (0.00-19.02) | <.001 | ||
| Regional hospital | 71.91 (19.90-235.61) | 61.90 (18.78-183.95) | 278.41 (64.85-946.18) | 107.37 (30.41-314.84) | 57.08 (15.07-178.88) | <.001 | 34.40 (8.50-109.28) | <.001 | ||
| Medical center | 6.35 (0.00-67.90) | 6.93 (0.00-60.93) | 68.37 (0.00-598.16) | 13.52 (0.00-107.51) | 2.82 (0.00-44.52) | <.001 | 0.00 (0.00-17.78) | <.001 | ||
aData are presented as median expense in US $ per person per year (IQR).
bICD-9-CM: International Classification of Diseases, Ninth Revision, Clinical Modification.
cCNS: central nervous system.
dCompared among the cancer groups and the no cancer group.
eCompared between all cancer survivors versus no cancer individuals.